CompletedNCT00015548

Antipsychotic medicines for behavior changes in Alzheimer’s disease

About this title

Medication studyUnited StatesSchizophrenia

The study in practice

Understand this study

Listed locations: Tuscaloosa and 33 more locationsSee all locations and recruitment

Study clarity

Study start dateMarch 2001

Recruitment status: Completed
Enrollment listed in the registry: 450
Sponsor: National Institute of Mental Health (NIMH)
Sponsor type: Government agency
Study type: Drug
Intervention type: Drug
Locations: United States
Age range: Not clearly listed
Official registry ID: NCT00015548
Official title: Show the full official title
Comparative Effectiveness of Antipsychotic Medications in Patients With Alzheimer's Disease (CATIE Alzheimer's Disease Trial)

Completed

Tuscaloosa · Irvine · Los Angeles

29 more locations

FAQ

Who is behind this study?

The study sponsor is National Institute of Mental Health (NIMH), a government agency.

Did this study involve medication?

Yes. The study involved medication, including Olanzapine, Quetiapine, Risperidone and Citalopram.